HIPAA Notice of Privacy Practices

We may use and disclose your PHI for the following purposes without your written authorization:

• Treatment — to provide, coordinate, or manage your care, including consultations with other treating clinicians.
• Payment — to obtain payment or reimbursement for the services we provide, including insurance verification and billing.
• Health care operations — to conduct quality assessment, training, accreditation, and other administrative functions of the practice.
• Required by law — when disclosure is required by federal, state, or local law (including mandated reporting of suspected abuse or threats of harm).
• Public health and safety — to prevent a serious threat to health or safety, or as required by public health authorities.

Other uses and disclosures of your PHI not described in this Notice will be made only with your written authorization, which you may revoke at any time in writing.

Records of substance use disorder treatment are protected by federal regulation 42 CFR Part 2 in addition to HIPAA. These regulations generally prohibit us from disclosing identifying information about a patient unless you consent in writing, the disclosure is allowed by a court order, or specific narrow exceptions apply (such as medical emergencies and qualified research).

We reserve the right to change this Notice at any time. Changes apply to all PHI we maintain. We will post the revised Notice on this website and make paper copies available at our office.

Effective date: May 25, 2026.